Related Experiment Video
Updated: Dec 22, 2025

Culturing and Measuring Fetal and Newborn Murine Long Bones
Published on: April 26, 2019
Bone mass development and bone metabolism in juvenile idiopathic arthritis: treatment with growth hormone for 4 years
Susanne Bechtold1, Peter Ripperger, Walter Bonfig
1Endocrine Division, University Children's Hospital, Dr. von Haunersches Kinderspital, Lindwurmstrasse 4, 80337 Munich, Germany. Susanne.Bechtold@med.uni-muenchen.de
Insights
Growth hormone (GH) therapy in children with juvenile idiopathic arthritis (JIA) increased bone turnover and stabilized volumetric bone mineral density (vBMD) over four years. Long-term studies are needed to confirm GH
Area of Science:
- Pediatric Endocrinology
- Rheumatology
- Bone Metabolism
Background:
- Juvenile idiopathic arthritis (JIA) can affect bone mass acquisition.
- Growth hormone (GH) therapy is used in pediatric conditions, but its effect on bone density in JIA is not fully understood.
Purpose of the Study:
- To longitudinally assess bone mass and bone mineral density (BMD) changes in children with JIA undergoing GH therapy.
- To compare bone acquisition in JIA patients with healthy children.
Main Methods:
- Dual-energy x-ray absorptiometry (DXA) was used to measure bone mineral content (BMC) and BMD.
- Volumetric BMD (vBMD) was calculated after adjusting for vertebral size.
- Measurements were taken over 4 years in 11 children with JIA.
Main Results:
- Children with JIA had low BMD at baseline (mean aBMD z-score -2.04).
- Four years of GH treatment significantly increased vBMD (p < 0.03) and bone turnover markers.
- vBMD changes relative to age and bone age were comparable to healthy children.
Conclusions:
- GH therapy increases bone turnover in children with JIA.
- vBMD stabilized during GH treatment, showing potential for bone density improvement.
- Long-term GH treatment efficacy on bone density and metabolism in JIA requires further investigation.
Objective:
To study the acquisition of bone mass and changes in bone mineral density (BMD) related to age, bone age, pubertal status, and growth hormone (GH) therapy in 11 children with juvenile idiopathic arthritis (JIA) longitudinally over 4 years, in comparison to healthy children.
Methods:
Bone mineral content (BMC), BMD, and vertebral area were measured by dual energy x-ray absorptiometry. Since BMC and BMD increase with size, BMD was converted to volumetric BMD (vBMD) after adjustment for vertebral size.
Results:
At inclusion all patients (7 female, 4 male, mean age 10.3 +/- 2.1 yrs) had low BMD, with a mean z-score for area BMD (aBMD) of -2.04 +/- 0.8 SD. After adjustment for size, vBMD was 0.198 g/cm3, and after 4 years of GH treatment it increased significantly to 0.232 g/cm3 (p < 0.03), expressed as SD scores that increased from -2.97 +/- 0.81 SD to -2.83 +/- 0.67 SD. In relation to bone age, vBMD SD increased from -2.53 +/- 0.85 to -2.41 +/- 0.79. Compared to pretreatment values, bone formation and resorption markers increased significantly during treatment.
Conclusion:
Our results reflect an increase in bone turnover under GH therapy in these patients. Despite biochemical changes there was a stabilization of vBMD for age and bone age, with a percentage increase comparable to healthy children. Longterm GH treatment will be necessary to evaluate a potential positive effect of GH on bone density and metabolism in patients with JIA.
More Related Videos
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Growth of Cartilage and Bone Tissue
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Formation by Endochondral Ossification
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...

